Published in J Subst Abuse Treat on June 27, 2007
Psychological mediators of bupropion sustained-release treatment for smoking cessation. Addiction (2008) 1.53
Treatment assignment guesses by study participants in a double-blind dose escalation clinical trial of saw palmetto. J Altern Complement Med (2013) 1.38
Long-term nicotine replacement therapy: a randomized clinical trial. JAMA Intern Med (2015) 1.06
Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study. Drug Alcohol Depend (2011) 0.90
Perceived treatment assignment and smoking cessation in a clinical trial of bupropion versus placebo. Nicotine Tob Res (2012) 0.77
Smokers' Treatment Expectancies Predict Smoking Cessation Success. J Smok Cessat (2014) 0.77
Perceived drug assignment and treatment outcome in smokers given nicotine patch therapy. J Subst Abuse Treat (2010) 0.76
Association between physician beliefs regarding assigned treatment and clinical response: re-analysis of data from the Hypericum Depression Trial Study Group. Asian J Psychiatr (2014) 0.75
Perceived medication assignment during a placebo-controlled laboratory study of varenicline: temporal associations of treatment expectancies with smoking-related outcomes. Psychopharmacology (Berl) (2014) 0.75
The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol (1986) 124.55
The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict (1991) 63.91
Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol (1988) 60.71
Biochemical verification of tobacco use and cessation. Nicotine Tob Res (2002) 14.54
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med (1999) 10.62
Assessment of blinding in clinical trials. Control Clin Trials (2004) 3.62
Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers. Tob Control (1996) 3.01
Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial. JAMA (2002) 3.00
Antidepressants for smoking cessation. Cochrane Database Syst Rev (2004) 2.61
Smoking withdrawal dynamics in unaided quitters. J Abnorm Psychol (2000) 2.11
Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. Neuropsychopharmacology (2006) 1.93
Mediating mechanisms for the impact of bupropion in smoking cessation treatment. Drug Alcohol Depend (2002) 1.65
Effect of nicotine on the tobacco withdrawal syndrome. Psychopharmacology (Berl) (1984) 1.55
Pharmacotherapy for nicotine dependence. CA Cancer J Clin (2005) 1.54
The blind spot in the nicotine replacement therapy literature: assessment of the double-blind in clinical trials. Addict Behav (2004) 1.46
Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers. J Consult Clin Psychol (2004) 1.41
Extended treatment with bupropion SR for cigarette smoking cessation. J Consult Clin Psychol (2006) 1.40
Relation between food reinforcement and dopamine genotypes and its effect on food intake in smokers. Am J Clin Nutr (2004) 1.34
Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial. Health Psychol (2003) 1.32
Placebo effects of tobacco smoking and other nicotine intake. Nicotine Tob Res (2003) 1.26
Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling. Nicotine Tob Res (2004) 1.24
Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion. Nicotine Tob Res (2005) 1.20
Bupropion for smoking cessation: a randomized trial. Arch Intern Med (2004) 1.18
Self-reported abstinence effects in the first month after smoking cessation. Addict Behav (2001) 1.15
Pharmacogenetic investigation of smoking cessation treatment. Pharmacogenetics (2002) 1.13
Do small lapses predict relapse to smoking behavior under bupropion treatment? Nicotine Tob Res (2004) 1.03
Changes in food reward following smoking cessation: a pharmacogenetic investigation. Psychopharmacology (Berl) (2004) 0.97
Effect of bupropion on depression symptoms in a smoking cessation clinical trial. Psychol Addict Behav (2004) 0.96
In randomized controlled trials, should subjects in both placebo and drug groups be expected to guess that they are taking drug 50% of the time? Med Hypotheses (2002) 0.89
Contributions from psychology to the study of drinking and driving. Q J Stud Alcohol (1968) 0.80
Genetic variation and cancer: improving the environment for publication of association studies. Cancer Epidemiol Biomarkers Prev (2004) 6.24
Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence. Nicotine Tob Res (2007) 5.54
BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol (2002) 4.38
Novel nicotine delivery systems and public health: the rise of the "e-cigarette". Am J Public Health (2010) 4.21
Sibling effects on smoking in adolescence: evidence for social influence from a genetically informative design. Addiction (2005) 4.01
Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol (2004) 3.88
Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. Addiction (2010) 3.26
Molecular genetics of successful smoking cessation: convergent genome-wide association study results. Arch Gen Psychiatry (2008) 3.12
Smoking cessation treatment on the Internet: content, quality, and usability. Nicotine Tob Res (2004) 3.06
Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial. Ann Intern Med (2010) 2.94
Smoking during pregnancy and newborn neurobehavior. Pediatrics (2003) 2.93
Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer. J Clin Oncol (2009) 2.52
Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clin Pharmacol Ther (2006) 2.49
Stress response and the adolescent transition: performance versus peer rejection stressors. Dev Psychopathol (2009) 2.46
Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst (2006) 2.42
Smoking cessation treatment by primary care physicians: An update and call for training. Am J Prev Med (2006) 2.36
Varenicline improves mood and cognition during smoking abstinence. Biol Psychiatry (2008) 2.29
Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing. Am J Med Genet A (2003) 2.29
Characteristics of smokers reached and recruited to an internet smoking cessation trial: a case of denominators. Nicotine Tob Res (2006) 2.28
Association of attention-deficit/hyperactivity disorder symptoms with levels of cigarette smoking in a community sample of adolescents. J Am Acad Child Adolesc Psychiatry (2002) 2.19
Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma. J Natl Cancer Inst (2008) 2.17
Does delay discounting play an etiological role in smoking or is it a consequence of smoking? Drug Alcohol Depend (2009) 2.15
Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. J Clin Oncol (2002) 2.13
Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. Hum Mol Genet (2008) 2.12
Neural substrates of abstinence-induced cigarette cravings in chronic smokers. J Neurosci (2007) 2.11
NIH working group report: Innovative research to improve maintenance of weight loss. Obesity (Silver Spring) (2014) 2.08
Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes. J Neurogenet (2009) 2.07
All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet (2002) 2.05
Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis. Cancer Epidemiol Biomarkers Prev (2008) 1.97
Elevated risk of tobacco dependence among offspring of mothers who smoked during pregnancy: a 30-year prospective study. Am J Psychiatry (2003) 1.95
Gender differences in acute tobacco withdrawal: effects on subjective, cognitive, and physiological measures. Exp Clin Psychopharmacol (2007) 1.94
Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. Neuropsychopharmacology (2006) 1.93
A randomized controlled trial of financial incentives for smoking cessation. Cancer Epidemiol Biomarkers Prev (2006) 1.93
Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study. Pharmacol Biochem Behav (2008) 1.90
Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype. J Nutr (2004) 1.90
Maternal smoking during pregnancy and newborn neurobehavior: effects at 10 to 27 days. J Pediatr (2008) 1.88
A prospective examination of distress tolerance and early smoking lapse in adult self-quitters. Nicotine Tob Res (2009) 1.87
History of depression and smoking cessation outcome: a meta-analysis. J Consult Clin Psychol (2003) 1.86
New lower nicotine cigarettes can produce compensatory smoking and increased carbon monoxide exposure. Drug Alcohol Depend (2006) 1.85
The role of CYP2A6 in the emergence of nicotine dependence in adolescents. Pediatrics (2006) 1.83
Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies. Cancer Epidemiol Biomarkers Prev (2009) 1.82
Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study. BMJ (2010) 1.77
Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior. Proc Natl Acad Sci U S A (2009) 1.76
A twin registry study of the relationship between posttraumatic stress disorder and nicotine dependence in men. Arch Gen Psychiatry (2005) 1.75
Early life stress and morphometry of the adult anterior cingulate cortex and caudate nuclei. Biol Psychiatry (2006) 1.74
The etiology of alcohol-induced breast cancer. Alcohol (2005) 1.73
The use of race variables in genetic studies of complex traits and the goal of reducing health disparities: a transdisciplinary perspective. Am Psychol (2005) 1.71
Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain. Neuropharmacology (2003) 1.70
The efficacy of moderate-intensity exercise as an aid for smoking cessation in women: a randomized controlled trial. Nicotine Tob Res (2005) 1.70
Cigarette smoking practices among American college students: review and future directions. J Am Coll Health (2004) 1.69
A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychol (2002) 1.69
Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving. Psychopharmacology (Berl) (2003) 1.68
Mediating mechanisms for the impact of bupropion in smoking cessation treatment. Drug Alcohol Depend (2002) 1.65
Relationship between education and delay discounting in smokers. Addict Behav (2004) 1.65
Assessing dimensions of nicotine dependence: an evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM). Nicotine Tob Res (2008) 1.62
Medication screening for smoking cessation: a proposal for new methodologies. Psychopharmacology (Berl) (2005) 1.62
Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. Am J Epidemiol (2003) 1.61
Applying a behavioral economic framework to understanding adolescent smoking. Psychol Addict Behav (2004) 1.61
Motivation and patch treatment for HIV+ smokers: a randomized controlled trial. Addiction (2009) 1.61
Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding. Cancer Res (2004) 1.59
Sibling effects on substance use in adolescence: social contagion and genetic relatedness. J Fam Psychol (2005) 1.56
Cigarette smoking and the lifetime alcohol involvement continuum. Drug Alcohol Depend (2007) 1.55
Patterns of change in depressive symptoms during smoking cessation: who's at risk for relapse? J Consult Clin Psychol (2002) 1.54
Barriers to translating emerging genetic research on smoking into clinical practice. Perspectives of primary care physicians. J Gen Intern Med (2005) 1.54
A smoking cessation intervention for the methadone-maintained. Addiction (2006) 1.53
Working memory deficits predict short-term smoking resumption following brief abstinence. Drug Alcohol Depend (2009) 1.53
Prevalence of depressive disorders in men and women enrolled in cardiac rehabilitation. J Cardiopulm Rehabil (2005) 1.53
Non-replication of genetic association studies: is DAT all, folks? Nicotine Tob Res (2002) 1.50
Interacting effects of genetic predisposition and depression on adolescent smoking progression. Am J Psychiatry (2004) 1.50
Negative mood, depressive symptoms, and major depression after smoking cessation treatment in smokers with a history of major depressive disorder. J Abnorm Psychol (2002) 1.49
The DRD4 VNTR polymorphism influences reactivity to smoking cues. J Abnorm Psychol (2002) 1.48
CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial. Biol Psychiatry (2007) 1.48
The efficacy of motivational interviewing versus brief advice for adolescent smoking behavior change. Pediatrics (2011) 1.48
Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. Arch Intern Med (2004) 1.48
Parent-child factors and their effect on communicating BRCA1/2 test results to children. Patient Educ Couns (2002) 1.47
Comparison of prior authorization and prospective audit with feedback for antimicrobial stewardship. Infect Control Hosp Epidemiol (2014) 1.45
CHRNA4 and tobacco dependence: from gene regulation to treatment outcome. Arch Gen Psychiatry (2007) 1.44
Combined effect of the metabolic syndrome and hostility on the incidence of myocardial infarction (the Normative Aging Study). Am J Cardiol (2005) 1.42
Comparison between two measures of delay discounting in smokers. Exp Clin Psychopharmacol (2003) 1.42
Food hedonics and reinforcement as determinants of laboratory food intake in smokers. Physiol Behav (2004) 1.41
Initial nicotine sensitivity in humans as a function of impulsivity. Psychopharmacology (Berl) (2008) 1.40
Facilitating transdisciplinary research: the experience of the transdisciplinary tobacco use research centers. Nicotine Tob Res (2003) 1.39
Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing. J Clin Oncol (2003) 1.38
Smoking topography predicts abstinence following treatment with nicotine replacement therapy. Cancer Epidemiol Biomarkers Prev (2004) 1.38
Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers. Biol Psychiatry (2010) 1.38
An association of CYP2A6 genotype and smoking topography. Nicotine Tob Res (2007) 1.37